Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Reed (1998)
Melanoma in situ: images, segments, appellations, and implications.Human pathology, 29 1
Phd KAKATI, M. SONG, MD SANDBERG, Roswell Park (1977)
Chromosomes and causation of human cancer and leukemia. XXII. Karyotypic changes in malignant melanomaCancer, 40
Marcory Dijk, S. Sprenger, P. Rombout, H. Marres, J. Kaanders, J. Jeuken, D. Ruiter (2003)
Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridizationGenes, 36
Koichiro Isshiki, D. Elder, D. Guerry, A. Linnenbach (1993)
Chromosome 10 allelic loss in malignant melanomaGenes, 8
Rosamaria Corona, Alfonso Mele, M. Amini, G. Rosa, G. Coppola, P. Piccardi, M. Fucci, Paolo Pasquini, Tullio Faraggiana (1996)
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 4
J. Harvell, B. Bastian, P. Leboit (2002)
Persistent (Recurrent) Spitz Nevi: A Histopathologic, Immunohistochemical, and Molecular Pathologic Study of 22 CasesThe American Journal of Surgical Pathology, 26
C. Sherr, R. DePinho (2000)
Cellular Senescence Minireview Mitotic Clock or Culture Shock?Cell, 102
E. Healy, I. Rehman, B. Angus, J. Rees (1995)
Loss of heterozygosity in sporadic primary cutaneous melanomaGenes, 12
B. Bastian (2003)
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancerOncogene, 22
D. Albertson, B. Ylstra, R. Segraves, C. Collins, S. Dairkee, D. Kowbel, W. Kuo, J. Gray, D. Pinkel (2000)
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNature Genetics, 25
B. Bastian, Jessie Xiong, I. Frieden, M. Williams, P. Chou, K. Busam, D. Pinkel, P. Leboit (2002)
Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.The American journal of pathology, 161 4
A. Ishkanian, C. Malloff, S. Watson, R. deLeeuw, Bryan Chi, Bradley Coe, A. Snijders, D. Albertson, D. Pinkel, M. Marra, V. Ling, C. MacAulay, W. Lam (2004)
A tiling resolution DNA microarray with complete coverage of the human genomeNature Genetics, 36
N. Bardeesy, B. Bastian, A. Hezel, D. Pinkel, R. DePinho, L. Chin (2001)
Dual Inactivation of RB and p53 Pathways in RAS-Induced MelanomasMolecular and Cellular Biology, 21
P. Heenan (2001)
Pitfalls in the histopathologic diagnosis of malignant melanoma.The American Journal of dermatopathology, 23 3
A. Kallioniemi, O. Kallioniemi, D. Sudar, D. Rutovitz, J. Gray, F. Waldman, D. Pinkel (1992)
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.Science, 258 5083
J. Maldonado, J. Fridlyand, Hetal Patel, Ajay Jain, K. Busam, T. Kageshita, T. Ono, D. Albertson, D. Pinkel, B. Bastian (2003)
Determinants of BRAF mutations in primary melanomas.Journal of the National Cancer Institute, 95 24
C. Sherr, R. DePinho (2000)
Cellular senescence: mitotic clock or culture shock?Cell, 102 4
B. Bastian, M. Kashani-Sabet, H. Hamm, T. Godfrey, D. Moore, E. Bröcker, P. Leboit, D. Pinkel (2000)
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.Cancer research, 60 7
G. Hodgson, J. Hager, S. Volik, S. Hariono, M. Wernick, D. Moore, D. Albertson, D. Pinkel, C. Collins, D. Hanahan, J. Gray (2001)
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomasNature Genetics, 29
M. Serrano, Han-Woong Lee, L. Chin, C. Cordon-Cardo, D. Beach, R. DePinho (1996)
Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 85
D. Slater (1998)
Diagnostic discord with melanomaThe Journal of Pathology, 184
F. Mertens, B. Johansson, M. Höglund, F. Mitelman (1997)
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.Cancer research, 57 13
H. Lynch, A. Chapelle (1999)
Genetic susceptibility to non-polyposis colorectal cancerJournal of Medical Genetics, 36
F. Thompson, J. Emerson, S. Olson, R. Weinstein, S. Leavitt, Stanley Leong, Scott Emerson, Jeffrey Trent, Mark Nelson, Sydney Salmon, R. Taetle (1995)
Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes.Cancer genetics and cytogenetics, 83 2
D. Millikin, E. Meese, B. Vogelstein, C. Witkowski, Jeffrey Trent (1991)
Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.Cancer research, 51 20
P. Mckee, Daniel foreword (1940)
PATHOLOGY OF THE SKINMedical Journal of Australia, 2
Robert Jackson (1997)
Malignant melanoma: a review of 75 malpractice casesInternational Journal of Dermatology, 36
M. Takata, R. Morita, K. Takehara (2000)
Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.International journal of cancer, 85 4
B. Bastian, Ulrich Wesselmann, D. Pinkel, P. Leboit (1999)
Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.The Journal of investigative dermatology, 113 6
W. Kempf, A. Haeffner, B. Mueller, R. Panizzon, G. Burg (1998)
Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology.The American Journal of dermatopathology, 20 5
Y. Cohen, E. Rosenbaum, S. Begum, D. Goldenberg, C. Esche, O. Lavie, D. Sidransky, W. Westra (2004)
Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed SitesClinical Cancer Research, 10
D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W. Kuo, Chira Chen, Y. Zhai, S. Dairkee, B. Ljung, J. Gray, D. Albertson (1998)
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 20
J. Maldonado, L. Timmerman, J. Fridlyand, B. Bastian (2004)
Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway.The American journal of pathology, 164 5
B. Bastian, A. Olshen, P. Leboit, D. Pinkel (2003)
Classifying melanocytic tumors based on DNA copy number changes.The American journal of pathology, 163 5
P. Leboit (1994)
Simulants of malignant melanoma: a rogue's gallery of melanocytic and nonmelanocytic imposters.Pathology, 2 2
J. Trent, F. Thompson, C. Ludwig (1984)
Evidence for selection of homogeneously staining regions in a human melanoma cell line.Cancer research, 44 1
L. Zuo, J. Weger, Qin Yang, A. Goldstein, M. Tucker, G. Walker, N. Hayward, N. Dracopoli (1996)
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaNature Genetics, 12
R. Wiltshire, T. Dennis, V. Sondak, P. Meltzer, J. Trent (2001)
Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma.Cancer genetics and cytogenetics, 131 2
M. Balázs, Z. Ádám, A. Treszl, Bégány A, J. Hunyadi, R. Ádány (2001)
Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization.Cytometry, 46 4
B. Bastian, P. Leboit, Henning Hamm, E. Bröcker, D. Pinkel (1998)
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.Cancer research, 58 10
R. Barnhill, Z. Argényi, L. From, L. Glass, J. Maize, M. Mihm, M. Rabkin, S. Ronan, W. White, M. Piepkorn (1999)
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.Human pathology, 30 5
M. Cook (1997)
Editorial. Diagnostic discord with melanomaThe Journal of Pathology, 182
Karin Veenhuizen, P. Wit, W. Mooi, E. Scheffer, A. Verbeek, D. Ruiter (1997)
Quality assessment by expert opinion in melanoma pathology: experience of the Pathology Panel of the Dutch Melanoma Working PartyThe Journal of Pathology, 182
M. Tronnier, M. Alexander, M. Neitmann, J. Brinckmann, H. Wolff (2000)
Morphologische Veränderungen in melanozytären Nävi durch exogene FaktorenDer Hautarzt, 51
The Consortium, V. Cheung, N. Nowak, W. Jang, I. Kirsch, S. Zhao, X.-N. Chen, T. Furey, U. Kim, W. Kuo, M. Olivier, J. Conroy, A. Kasprzyk, H. Massa, R. Yonescu, S. Sait, C. Thoreen, A. Snijders, E. Lemyre, J. Bailey, A. Bruzel, W. Burrill, S. Clegg, S. Collins, P. Dhami, C. Friedman, C. Han, S. Herrick, J. Lee, A. Ligon, S. Lowry, M. Morley, S. Narasimhan, K. Osoegawa, Z. Peng, I. Plajzer-Frick, B. Quade, D. Scott, K. Sirotkin, A. Thorpe, J. Gray, J. Hudson, D. Pinkel, T. Ried, L. Rowen, G. Shen-Ong, R. Strausberg, E. Birney, D. Callen, J. Cheng, D. Cox, N. Doggett, N. Carter, E. Eichler, D. Haussler, J. Korenberg, C. Morton, D. Albertson, G. Schuler, P. Jong, B. Trask (2001)
Integration of cytogenetic landmarks into the draft sequence of the human genomeNature, 409
W. Crutcher, P. Cohen (1990)
Dysplastic nevi and malignant melanoma.American family physician, 42 2
K. Peris, G. Keller, S. Chimenti, A. Amantea, H. Kerl, H. Höfler (1995)
Microsatellite instability and loss of heterozygosity in melanoma.The Journal of investigative dermatology, 105 4
M. Hoang, V. Prieto, J. Burchette, C. Shea (2001)
Recurrent melanocytic nevus: a histologic and immunohistochemical evaluationJournal of Cutaneous Pathology, 28
A. Hardy (2005)
MortalityThe Lancet, 365
E. Sauter, U. Yeo, A. Stemm, Weizhu Zhu, S. Litwin, D. Tichansky, G. Pistritto, M. Nesbit, D. Pinkel, M. Herlyn, B. Bastian (2002)
Cyclin D1 is a candidate oncogene in cutaneous melanoma.Cancer research, 62 11
W. Clark, A. Hood, M. Tucker, R. Jampel (1998)
Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.Human pathology, 29 1 Suppl 1
B. Bastian, P. Leboit, D. Pinkel (2000)
Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.The American journal of pathology, 157 3
J. Harvell, S. Kohler, Shirley Zhu, T. Hernandez-Boussard, J. Pollack, M. Rijn (2004)
High-Resolution Array-Based Comparative Genomic Hybridization for Distinguishing Paraffin-Embedded Spitz Nevi and MelanomasDiagnostic Molecular Pathology, 13
Lynch HT (1999)
801J Med Genet, 36
A. Snijders, N. Nowak, B. Huey, J. Fridlyand, Sindy Law, J. Conroy, T. Tokuyasu, K. Demir, Readman Chiu, J. Mao, Ajay Jain, Steven Jones, A. Balmain, D. Pinkel, D. Albertson (2005)
Mapping segmental and sequence variations among laboratory mice using BAC array CGH.Genome research, 15 2
Y. Sasaki, Chunbo Niu, Rui Makino, Chieko Kudo, Chunlan Sun, Hiroshi Watanabe, J. Matsunaga, Kazuhiro Takahashi, H. Tagami, S. Aiba, A. Horii (2004)
BRAF point mutations in primary melanoma show different prevalences by subtype.The Journal of investigative dermatology, 123 1
ABSTRACT: Cancer typically results in loosened control over genomic integrity, resulting in alterations of the genome of cancer cells. Comparative genomic hybridization (CGH) is a method that can be used on DNA extracted from routinely fixed tissue to assess the entire genome for the presence of changes in DNA copy number. CGH analysis has revealed that melanoma differs from melanocytic nevi by the presence of frequent chromosomal aberrations. In contrast, melanocytic nevi typically show no chromosomal aberrations, or have a restricted set of alterations with basically no overlap to melanoma. These marked differences between aberration patterns in melanomas and melanocytic nevi can be exploited diagnostically to classify melanocytic tumors that are ambiguous based on histopathologic assessment. In addition to potential diagnostic applications, detailed analyses of recurrent aberrations can lead to the identification of genes relevant in melanocytic neoplasia.
Dermatologic Therapy – Wiley
Published: Jan 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.